Ward Keith Wayne

CIK 00016623942 companiesIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001662394

Recent Transactions

50 trades

Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2024-02-29+35,000→ 35,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-11-06+14,110→ 20,001 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-08-25+1,472,692→ 1,472,692 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 total
Award
Skye Bioscience, Inc.$SKYE
Director Option Grant (Right to Buy)
2021-12-14+250,000→ 250,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-02-26−16,817→ 76,150 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-02-26$11.62/sh+8,367→ 25,184 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-02-26+25,184→ 33,804 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-02-26$91.00/sh−16,817→ 16,987 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-02-26−25,184→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-02-26−8,367→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-02-26$91.62/sh−8,367→ 8,620 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-02-26$11.00/sh+16,817→ 16,817 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-02-25$11.00/sh+15,183→ 15,183 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-02-25+15,183→ 23,803 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-02-25$91.00/sh−15,183→ 8,620 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-02-25−15,183→ 92,967 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-02-25−15,183→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-31−4,150→ 8,367 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-31$76.97/sh−2,750→ 8,620 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-31−4,150→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-31$11.62/sh+4,150→ 4,150 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-31$76.17/sh−1,400→ 11,370 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-31+4,150→ 12,770 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-14$11.62/sh+8,620→ 8,620 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-14−8,620→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-14+8,620→ 8,620 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-14−8,620→ 12,517 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-02$54.58/sh−1,320→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-02−4,150→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-02+4,150→ 4,150 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2019-01-02$53.71/sh−2,830→ 1,320 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-02−4,150→ 21,137 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2019-01-02$11.62/sh+4,150→ 4,150 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-02+34,500→ 34,500 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-07$68.13/sh−1,053→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2018-11-07−4,750→ 25,287 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-11-07−4,750→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-07$66.64/sh−3,697→ 1,053 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-11-07$11.62/sh+4,750→ 4,750 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-07+4,750→ 4,750 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-01+4,750→ 4,750 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2018-11-01−4,750→ 30,037 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2018-11-01$59.48/sh−4,750→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-11-01−4,750→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-11-01$11.62/sh+4,750→ 4,750 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2018-10-23+14,250→ 14,250 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2018-10-23−14,250→ 34,787 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-10-23$11.62/sh+14,250→ 14,250 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2018-10-23−14,250→ 0 total

Companies

Recent Filings

Address

2801 GATEWAY DRIVE, SUITE 150

IRVING, TX, 75063

View on SEC.gov